tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Cardiff Oncology price target raised to $18 from $17 at H.C. Wainwright

H.C. Wainwright analyst Robert Burns raised the firm’s price target on Cardiff Oncology (CRDF) to $18 from $17 and keeps a Buy rating on the shares following the Q1 report.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1